[Eosinophilia-myalgia syndrome with fasciitis and interstitial myositis after L-tryptophan administration].
We describe a 53-year-old women with eosinophilia-myalgia syndrome who suddenly developed severe persistent myalgias of her arms, legs, back, and shoulder after a 5-month period of daily L-tryptophan ingestion, associated with fever, progressive stenocardia and left-sided congestive heart failure. Laboratory tests showed a leukocytosis of 11.2/nl with 3.14/nl eosinophils and an elevated erythrocyte sedimentation rate. There was a marked, predominantly proximal sclerosis of her arms, legs and trunk with a brownish discoloration. The skin of her arms and legs appeared dimpled (peau d'orange). Findings of the electrophysiological examinations were consistent with sensory neuropathy and myositis. Remarkable fasciitis and interstitial myositis were present in a biopsy specimen (from skin to muscle) taken from her thigh. However, eosinophilic infiltrates were rare. Angiography revealed an apical obstructive cardiomyopathy. In this paper, we describe the clinical findings, the course over 2 years, as well as the therapeutic management. Furthermore, the most important differential diagnoses are discussed and the literature is reviewed with special attention given to more recent pathogenic insights into this newly recognized multisystem disease.
Bartz-Bazzanella
P
P
Rheumaklinik, Rheinisch-Westfälischen Technischen Hochschule Aachen.
Genth
E
E
Pollmann
H J
HJ
Schröder
J M
JM
Völker
A
A
D001706:Biopsy; D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis / Q000473:pathology; D016603:Eosinophilia-Myalgia Syndrome / Q000175:diagnosis* / Q000473:pathology; D005208:Fasciitis / Q000175:diagnosis* / Q000473:pathology; D005260:Female; D006801:Humans; D008875:Middle Aged; D009132:Muscles / Q000473:pathology; D009220:Myositis / Q000175:diagnosis* / Q000473:pathology; D011115:Polyneuropathies / Q000175:diagnosis / Q000473:pathology; D012867:Skin / Q000473:pathology; D014364:Tryptophan / Q000008:administration & dosage / Q000009:adverse effects*
D014364:Tryptophan
Eosinophilie-Myalgie-Syndrom mit Fasziitis und interstitieller Myositis nach L-Tryptophan-Einnahme.